Ignite Creation Date:
2025-12-24 @ 10:32 PM
Ignite Modification Date:
2026-01-16 @ 5:11 AM
Study NCT ID:
NCT05106335
Status:
TERMINATED
Last Update Posted:
2023-08-16
First Post:
2021-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Camrelizumab Combined With Famitinib as Subsequent Therapy in Patients With Advanced NSCLC
Sponsor:
Organization: